Back to 
Connor, Clark & Lunn Investment Management Ltd.
Connor, Clark & Lunn Investment Management Ltd.
QNCX
Showing 0 of 2 quarters
Position history for Connor, Clark & Lunn Investment Management Ltd.'s holdings in QUINCE THERAPEUTICS INC
No. Connor, Clark & Lunn Investment Management exited its QNCX (Quince Therapeutics) position in Q4 2022. Its Q3 2022 13F listed 17,275 shares worth $23,000. Connor, Clark & Lunn Investment Management first reported QNCX in Q3 2022 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.